Minn. Pension Fund Seeks Pfizer Price Drop Managers of Minnesota's $43-billion pension fund propose a shareholder resolution that would require drug giant Pfizer to lower prescription drug prices in the United States. Critics say the effort could backfire, harming Pfizer's stock price and lowering the value of the state's retiree pension fund. Minnesota Public Radio's Tom Scheck reports.
NPR logo

Minn. Pension Fund Seeks Pfizer Price Drop

  • Download
  • <iframe src="https://www.npr.org/player/embed/1778056/1778057" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Minn. Pension Fund Seeks Pfizer Price Drop

Minn. Pension Fund Seeks Pfizer Price Drop

Minn. Pension Fund Seeks Pfizer Price Drop

  • Download
  • <iframe src="https://www.npr.org/player/embed/1778056/1778057" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Managers of Minnesota's $43-billion pension fund propose a shareholder resolution that would require drug giant Pfizer to lower prescription drug prices in the United States. Critics say the effort could backfire, harming Pfizer's stock price and lowering the value of the state's retiree pension fund. Minnesota Public Radio's Tom Scheck reports.